The purpose of this study is to assess the efficacy of esomeprazole (D961H) 20 mg versus
placebo once daily for up to 24 weeks of treatment involving patients with a history of
gastric and/or duodenal ulcers receiving daily nonsteroidal anti-inflammatory drug (NSAID)
therapy by evaluating presence or absence of gastric and/or duodenal ulcers throughout the
treatment period (24 weeks) in terms of efficacy on prevention of gastric and/or duodenal
ulcers
Minimum age: 20 Years.
Maximum age: N/A.
Gender(s): Both.
Research Site, Kyoto, Japan
Research Site, Nagano, Japan
Research Site, Oita, Japan
Research Site, Osaka, Japan
Research Site, Saitama, Japan
Research Site, Shizuoka, Japan
Research Site, Chiryu, Aichi, Japan
Research Site, Seto, Aichi, Japan
Research Site, Yotukaido, Chiba, Japan
Research Site, Mizumaki, Fukuoka, Japan
Research Site, Akashi, HYOGOi, Japan
Research Site, Sapporo, Hokkaido, Japan
Research Site, Itami, Hyogo, Japan
Research Site, Koto, Hyogo, Japan
Research Site, Nishinomiya, Hyogo, Japan
Research Site, Hitachi, Ibaragi, Japan
Research Site, Morioka, Iwate, Japan
Research Site, Sagamihara, Kanagawa, Japan
Research Site, Yokohama, Kanagawa, Japan
Research Site, Nagaokakyo, Kyoto, Japan
Research Site, Chiisagata, Nagano, Japan
Research Site, Matsumoto, Nagano, Japan
Research Site, Sasebo, Nagasaki, Japan
Research Site, Beppu, Oita, Japan
Research Site, Ihara, Okayama, Japan
Research Site, Hirakata, Osaka, Japan
Research Site, Sakai, Osaka, Japan
Research Site, Suita, Osaka, Japan
Research Site, Takatsuki, Osaka, Japan
Research Site, Kawagoe, Saitama, Japan
Research Site, Fukuroi, Shizuoka, Japan
Research Site, Hamamatsu, Shizuoka, Japan
Research Site, Izunokuni, Shizuoka, Japan
Research Site, Maikinohara, Shizuoka, Japan
Research Site, Yaizu, Shizuoka, Japan
Research Site, Shimotsuke, Tochigi, Japan
Research Site, Chiyoda, Tokyo, Japan
Research Site, Koto, Tokyo, Japan
Research Site, Musashimurayama, Tokyo, Japan